Literature DB >> 2707268

Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death.

M J Davies1, J M Bland, J R Hangartner, A Angelini, A C Thomas.   

Abstract

Sudden ischaemic death results either from an episode of acute myocardial ischaemia consequent upon coronary thrombosis or from an arrhythmia arising within a scarred left ventricle. Very different proportions of these two groups have been reported in both clinical studies in resuscitated subjects with out-of-hospital ventricular fibrillation, and in necropsy series. In 168 cases of sudden death due to ischaemic heart disease coming to necropsy 73 (43.5%) had mural intraluminal coronary thrombi, 50 (29.8%) had occlusive intraluminal thrombi, and 45 (26.7%) had no intraluminal thrombi, giving a ratio of 2.7:1 for those with and without coronary thrombosis. Single vessel disease, the presence of acute infarction at autopsy and prodromal symptoms were positively associated with the presence of coronary thrombosis. Conversely, the presence of old myocardial infarction at necropsy, a known clinical history of ischaemic heart disease and triple vessel disease were associated with the absence of acute thrombosis. The reported variation in the incidence of coronary thrombi in sudden ischaemic death can be largely explained by selection of subjects with those clinical characteristics which are positively or negatively associated with coronary thrombosis.

Entities:  

Mesh:

Year:  1989        PMID: 2707268     DOI: 10.1093/oxfordjournals.eurheartj.a059467

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  36 in total

Review 1.  Spontaneous and iatrogenic microembolization. A new concept for the pathogenesis of coronary artery disease.

Authors:  R Erbel; G Heusch
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

2.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 3.  Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.

Authors:  R A Archbold; A D Timmis
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

4.  Spontaneous and interventional coronary microembolisation.

Authors:  R Erbel
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

5.  Atherosclerotic plaque rupture and acute ischemia.

Authors:  A Langer
Journal:  CMAJ       Date:  1991-06-15       Impact factor: 8.262

6.  Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.

Authors:  H Douglas; K Michaelides; D A Gorog; E Durante-Mangoni; N Ahmed; G J Davies; E G D Tuddenham
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

7.  Mechanisms of progression in native coronary artery disease: role of healed plaque disruption.

Authors:  J Mann; M J Davies
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

Review 8.  Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris.

Authors:  F C Schoebel; T W Jax; Y Fischer; B E Strauer; M Leschke
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

Review 9.  Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.

Authors:  J M Wilson; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1995

10.  Gender-based mortality follow-up from the Program on the Surgical Control of the Hyperlipidemias (POSCH) and meta-analysis of lipid intervention trials. Women in POSCH and other lipid trials.

Authors:  H Buchwald; C T Campos; J R Boen; P Nguyen; S E Williams; J Lau; T C Chalmers
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.